Brady Todd C (CIK 0001579179)

Latest company ownership

Shares held
1,081,201
Last filed at
Mar 12, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q2 2025Q4
EVOK - Evoke Pharma Inc
Role: Director
Shares held
14,625
Last filed at
May 24, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 11, 2024 Mar 12, 2024 Aldeyra Therapeutics, Inc. CEO Sell 40.0 -183,238 -11.07% ✗ $580.8K
Sep 7, 2023 Sep 11, 2023 Aldeyra Therapeutics, Inc. CEO Sell 40.0 -73,807 -4.27% ✗ $532.9K
Jun 23, 2022 Jun 27, 2022 Aldeyra Therapeutics, Inc. CEO Buy 82.5 +17,700 1.48% ✗ $59.5K
Dec 16, 2019 Dec 18, 2019 Aldeyra Therapeutics, Inc. CEO Buy 87.5 +20,000 3.16% ✗ $101.9K
Sep 30, 2019 Oct 2, 2019 Aldeyra Therapeutics, Inc. CEO Buy 78.8 +8,710 1.40% ✓ $49.5K
Sep 23, 2019 Sep 25, 2019 Aldeyra Therapeutics, Inc. CEO Buy 82.5 +8,680 1.41% ✓ $50.4K
Sep 18, 2019 Sep 20, 2019 Aldeyra Therapeutics, Inc. CEO Buy 82.5 +14,288 2.38% ✗ $84.5K
Sep 13, 2019 Sep 17, 2019 Aldeyra Therapeutics, Inc. CEO Buy 87.5 +21,547 3.72% ✗ $127.4K
Sep 13, 2019 Sep 17, 2019 Aldeyra Therapeutics, Inc. CEO Buy 82.5 +13,000 2.25% ✗ $76K
Sep 9, 2019 Sep 11, 2019 Aldeyra Therapeutics, Inc. CEO Buy 87.5 +20,000 3.58% ✗ $102.8K
Feb 17, 2017 Feb 21, 2017 Aldeyra Therapeutics, Inc. CEO Buy 95.0 +22,223 52.68% ✗ $100K
Sep 23, 2014 Sep 24, 2014 Evoke Pharma Inc Director Buy 91.3 +4,000 100.00% ✗ $22.8K
May 7, 2014 May 8, 2014 Aldeyra Therapeutics, Inc. CEO Buy 95.0 +12,500 482.81% ✗ $100K